SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-026608
Filing Date
2022-11-09
Accepted
2022-11-09 16:20:26
Documents
15
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20221108_8k.htm   iXBRL 8-K 29500
2 EXHIBIT 99.1 ex_444616.htm EX-99.1 168303
7 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-22-026608.txt   370621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20221109.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20221109_def.xml EX-101.DEF 11517
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20221109_lab.xml EX-101.LAB 15384
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20221109_pre.xml EX-101.PRE 11673
9 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20221108_8k_htm.xml XML 2561
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 221372947
SIC: 2834 Pharmaceutical Preparations